Browse > Article

EFFECT OF CURCUMIN AND RESVERATROL ON THE CELL CYCLE REGULATION, APOPTOSIS AND INHIBITION OF METASTASIS RELATED PROTEINS IN HN-4 CELLS  

Kim, Sa-Yub (Dept. of Oral & Maxillofacial Surgery, School of Dentistry, Kyungpook National University)
Lee, Sang-Han (Dept. of Oral & Maxillofacial Surgery, School of Dentistry, Kyungpook National University)
Kwon, Taeg-Kyu (Dept. of Immunology, School of Medicine, Kyemyung University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.29, no.5, 2003 , pp. 272-281 More about this Journal
Abstract
Nontraditional or alternative medicine is becoming an increasingly attractive approach for the treatment of various inflammatory disorders and cancers. Curcumin is the major constitute of turmoric powder extracted from the rhizomes of the plant Curcuma longa. Resveratrol is a phytoalexin present in grapes and a variety of medicinal plants. In this report, We investigated the effect of curcumin and resveratrol on regulatory protein of cell cycle, induction of apoptosis and MMP activity. Treatment with 75 M curcumin for 24 hrs produced morphological changing in HN-4 cells. Curcumin and resveratrol inhibited the cellular growth in HN-4 cells. Inhibition of cell growth was associated with down-regulation of cell cycle regulatory proteins. Curcumin-induced caspase-3 activation and Bax degradation were dose-dependent with a maximal effect at a concentration of 100 M. The elevated caspase-3 activity in curcumin treated HN-4 cells are correlated with down-regulation of survivin and cIAP1, but not cIAP2. Curcumin induced a dose-dependent increase of cytochrome c in the cytosol. Curcumin induced-apoptosis was mediated through the release of cytochrome c. In addition, curcumin-induced apoptosis was caused by the generation of reactive oxygen species, which was prevented by antioxidant N-acetyl-cysteine (NAC). Cotreatment with NAC markedly prevented cytochrome c release, Bax cleavage and cell death. Also resveratrol-induced apoptosis was preceded by down-regulation of the anti-apoptotic Bcl-2, cIAP1, and caspase-3 activity. However, resveratrol-induced apoptosis was not prevented by antioxidant NAC. In addition, HN-4 cells release basal levels of MMP2 when cultured in serum-free medium. Treatment of the cells with various concentrations of PMA for 24 hr induced the expression and secretion of latent MMP9 as determined by gelatin zymography. HN-4 cells were treated with various concentrations of curcumin and resveratrol in the presence of 75 nM PMA, and MMP2 and 9 activities were inhibited by curcumin and resveratrol. These findings have implications for developing curcumin-based anticancer and anti-inflammation therapies.
Keywords
Curcumin; Resveratrol; Cancer chemopreventive agent;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Huang MT, Smart RC, Wong CQ, and Conney AH : Inhibitory effect of curcumin, chlorogenic acid, caffeicacid, and ferulic acid on tumor promotion in mouse skin by\12-O-tetradecanoylphor bol-13-acetate. Cancer Res., 1998 ; 48 : 5941-5946.
2 Huang MT, Newmark HL, and Frenkel K : Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl., 1997 ; 27 : 26-34.
3 Soleas, GJ., Diamandis, EP., and Goldberg, DM. : Resveratrol: a molecule whose time has come? And gone? Clin. Biochem., 1997 ; 30 : 91-113.
4 Fremont, L. : Biochemical effect of resveratrol. Life Sci., 2000 ; 66 : 6663-6673.
5 Jang, M., Cai, L., Udeani, GO., Slowing, KV., Thomas, CF., Beecher, CW. Fong, HH., Farnsworth, NR., Kinghorn, AD., Mehta, RG., Moon, RC., and Pezzuto, JM. : Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997 ; 275 : 218-220.   DOI   ScienceOn
6 Mgbonyebi, OP., Russo, J., and Russo, IH. : Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol., 1998 ; 12 : 865-869.
7 Morgan, DO. : Principles of CDK regulation. Nature, 1995 ; 374: 131-134.   DOI   PUBMED   ScienceOn
8 Thompson, CB. : Apoptosis in the pathogenesis and treatment of disease. Science, 1995 ; 267: 1456-1462.   DOI   PUBMED   ScienceOn
9 Tsujimoto, Y., Jaffe, E., Cossman, J., Gorham, J., Nowell, PC. and Croce, CM. : Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature, 1985 ; 315: 340-343.
10 Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H. and Tsujimoto, Y. : Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature, 1995 ; 374: 811-813.
11 Mashima, T., Naito, M., Noguchi, K., Miller, DK., Nicholson, DW. and Tsuruo, T.: Actin cleavage byCPP-32/apopain during the development of apoptosis. Oncogene, 1997 ; 14: 1007-1012.
12 Stamenkovic, I. : Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol., 2000 ; 10: 415-433.
13 Curran, S. and Murray, G. I. : Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer, 2000 ; 36: 1621-1630.
14 Nunez, G., Benedict, MA., Hu, Y. and Inohara. N. : Caspases: the proteases of the apoptotic pathway. Oncogene, 1998 ; 17: 3237-3245.
15 Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, SM., Ahmad, M., Alnemri, ES. and Wang, X. : Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 1997 ; 91: 479-489.
16 Islam, S., Islam, N., Kermode, T., Johnstone, B., Mukhtar, H., Moskowitz, RW., Goldberg, VM., Malemud, CJ. and Haqqi, TM. : Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells Biochem. Biophys. Res. Commun., 2000 ; 270:793-797.
17 An, B. and Dou, QP. : Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res., 1996 ; 56: 438-442.
18 Tsujimoto, Y. and Croce, CM. : Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. U. S. A. 1986 ; 83: 5214-5218.
19 Nelson, AR., Fingleton, B., Rothenberg, ML. and Matrisian, LM. : Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol., 2000 ; 18: 1135-4119.
20 Sherr, CJ. and Roberts, JM. : Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev. 1995 ; 9: 1149-1163.
21 Moberg, K., Starz, MA. and Lees, JA. : E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 1996 ; 16: 1436-1449.
22 Tudor, G., Aguilera, A,. Halverson, DO. ,Laing, ND. and Sausville, EA. : Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ., 2000 ; 7: 574-586.
23 illardon, F., Moll, I., Meyer, M. and Michaelidis, TM. : Alterations in cell death and cell cycle progression in the UV-irradiated epidermis of bcl-2-deficient mice. Cell Death Differ., 1999 ; 6: 55-60.
24 Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, Mehta MU, Temeck JW, Schmidt WJ, Burke G, and Sigman CC : Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol. Biomarkers Prev., 1995 ; 4 :1-10.
25 Fauconneau, B., Waffo-Teguo, P., Huguet, F. Barrier, L., Decendit, A., and Merillon, JM. : Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci., 1997 ; 61 : 2103-2110.
26 Surh, YJ., Hurh, YJ., Kang, JY., Lee, E., Kong, G., and Lee, SJ. : Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL60) cells. Cancer letters, 1999 ; 140:1-10.   DOI   ScienceOn
27 Kluck, RM., Bossy-Wetzel, E., Green, DR. and Newmeyer, DD. : The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 1997 ; 275: 1132-1136.
28 Koriyama, H., Kouchi, Z., Umeda, T., Saido, TC., Momoi, T., Ishiura, S. and Suzuki, K. : Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cell Signal., 1999 ; 11: 831-838.
29 Grutter, MG. : Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol., 2000 ; 10: 649-655.
30 Kyprianou, N., King, ED., Bradbury, D. and Rhee, JG. : bcl-2 overexpression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int. J. Cancer, 1997 ; 70: 341-348.
31 Park, JW., Choi, YJ., Suh, SI., Baek, WK., Suh, MH., Jin, IN., Min, DS., Woo, JH., Chang, JS., Passaniti, A., Lee, YH. and Kwon, TK. : Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis, 2001 ; 22: 1633-1639.
32 Zhang, Y., Fujita, N. and Tsuruo, T. : Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 1999 ; 18: 1131-1138.
33 Soleas, GJ., Diamandis, EP., and Goldberg, DM. : Wine as a biological fluid:history, production, and role in disease prevention. J. Clin. Lab. Anal., 1997 ; 11: 287-313.
34 Clement, MV., Hirpara, JL., Vhawdhury, SH., and Pervaiz, S. : Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998 ; 92: 996-1002.
35 Lawrence, MS., Ho, DY., Sun, GH.,Steinberg, GK. and Sapolsky, RM. : Over expression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci., 1996 ; 16: 486-496.
36 Ames BN, Gold LS, and Willett WC : The causes and prevention of cancer. Proc. Natl. Acad. Sci. U. S. A., 1995 ; 92 : 5258-5265.
37 Ammon HP, and Wahl MA : Pharmacology of Curcuma longa. Planta. Med., 1991 ; 57 :1-7.
38 John, A. and Tuszynski, G. : The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res., 2001 ; 7: 14-23.
39 Chung, LY., Cheung, TC., Kong, SK., Fung, KP., Choy, YM., Chan, ZY. and Kwok, TT. : Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci., 2001 ; 68: 1207-1214.
40 Pace-Asciak, CR., Rounova, O., Hahn, SE., Diamandis, EP., and Goldberg, DM. : The red wine phenolics trans resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis :Implication for protection against coronary heart disease. Clin. Chim. Acta., 1996 ; 246 :163-182.
41 Decker, P., Isenberg, D. and Muller, S. : Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J. Biol. Chem., 2000 ; 275: 9043-9046.
42 Wyllie, AH. : Apoptosis. Br. J. Cancer, 1993 ; 67: 205-208.
43 Srinivasula, SM., Ahmad, M., Fernandes-Alnemri, T. and Alnemri, ES. :Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell, 1998 ; 1: 949-957.
44 Ragione, FD., Cucciolla, V., Borriello, A., Pietra, VD., Racioppi, L., Soldati, G., Manna, C., Galletti, P., and Zappia, V. : Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun., 1998 ; 250: 53-58.
45 Hunter, T. and Pines, J. : Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 1994 ; 79: 573-82.
46 Ikeda, MA., Jakoi, L. and Nevins, JR. : A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. U. S. A. 1996 ; 93: 3215-3220.
47 Yang, J., Liu, X., Bhalla, K., Kim, CN., Ibrado, AM., Cai, J., Peng, TI., Jones, DP. and Wang, X. : Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 1997 ; 275: 1129-1132.
48 Park, JW., Choi, YJ., Jang, MA., Lee, YS., Jun, DY., Suh, SI., Baek, WK., Suh, MH., Jin, IN. and Kwon, TK. : Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett., 2001 ; 163: 43-49.